TRANSCAT INC (TRNS) stock: key figures, P/E, revenue and dividend
Information Technology · United States · ISIN US8935291075
TRANSCAT INC financials
| Fiscal year | 2025 | 2026 |
|---|---|---|
| Revenue | 278.42 m USD | 331.88 m USD |
| Gross profit | 89.45 m USD | 108.30 m USD |
| Operating income | 17.87 m USD | 13.26 m USD |
| EBIT | 18.30 m USD | 12.57 m USD |
| Net income | 14.52 m USD | 5.38 m USD |
| Diluted EPS – continuing operations | 1.57 USD | 0.57 USD |
Full history since 1987, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About TRANSCAT INC
Transcat, Inc. provides calibration and laboratory instrument services in the United States, Canada, and internationally. The company operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services. This segment also provides CalTrak, a proprietary document and asset management system that is used to manage the workflow of its calibration service centers and customers' assets; and Compliance, Control, and Cost, an online customer portal that provides its customers with web-based asset management capability, as well as a safe and secure off-site archive of calibration and other service records. The Distribution segment sells and rents test, measurement, and control instruments for customers' test and measurement instrumentation needs, as well as value-added services, such as calibration/certification of equipment purchase, equipment rental, used equipment for sale, and equipment kitting. This segment markets and sells its products through website, digital and print advertising, proactive outbound sales, and an inbound call center. The company provides services and products to highly regulated industries, principally life science, which includes companies in the pharmaceutical, biotechnology, medical device, and other FDA-regulated industries; and additional industries, including aerospace and defense, industrial manufacturing, energy and utilities, oil and gas, chemical manufacturing, and other industries that require accuracy in processes and confirmation of the capabilities of their equipment. Transcat, Inc. was incorporated in 1964 and is headquartered in Rochester, New York.
More stocks
- Carlsberg Brewery Malaysia Bhd (2836.KL)
- Aktia Bank Abp (AKTIA.HE)
- Aussie Broadband Ltd (ABB.AX)
- Gryphon Capital Income Trust (GCI.AX)
- Conduit Holdings Ltd (CRE.L)
- Orchid Island Capital, Inc. (ORC)
- Warom Technology Inc Co (603855.SS)
- B2 Impact ASA (B2I.OL)
- EST Tools Co Ltd (300488.SZ)
- McEwen Inc. (MUX)
- Jiangsu Shentong Valve Co Ltd (002438.SZ)
- Akasha Wira International Tbk (ADES.JK)
Not investment advice. All data without warranty, price as of 05.11.2026. Details in the risk notice.